B. Agoram

Systems Pharmacology Models Can Be Used to Understand Complex Pharmacokinetic-Pharmacodynamic Behavior: An Example Using 5-Lipoxygenase Inhibitors

O Demin, P. H. van der Graaf, D. Fairman, 2013, CPT: pharmacometrics & systems pharmacology.

Effects of IL-1β–Blocking Therapies in Type 2 Diabetes Mellitus: A Quantitative Systems Pharmacology Modeling Approach to Explore Underlying Mechanisms

G. Cedersund, E. Nyman, G Cedersund, 2014, CPT: pharmacometrics & systems pharmacology.

A Mathematical Modeling Approach to Understanding the Effect of Anti‐Interleukin Therapy on Eosinophils

G. Colice, O. Demin, T. Karelina, 2016, CPT: pharmacometrics & systems pharmacology.

Evaluating Systems Pharmacology Models Is Different From Evaluating Standard Pharmacokinetic–Pharmacodynamic Models

B. Agoram, B Agoram, 2014, CPT: pharmacometrics & systems pharmacology.